Invo Fertility Inc (IVF) 13F Ownership Report (Q2 2026)

IVF ranks #10297 out of 37696 tracked stocks by institutional interest, inside the more closely watched half of our coverage.

9 institutions disclose a position in IVF, but none treat it as a major bet — even Scientech Research LLC, its most concentrated holder, allocates just 0.1% of its own portfolio to it.

IVF reported a net loss of $6.0M over the trailing twelve months.

• Not yet profitable — net loss of $6.0M over the trailing twelve months
• Revenue grew 13.8% year over year
• Net income improved year over year, from -$26.4M to -$6.0M
• Operating cash flow was negative, using $7.0M in cash
• Current ratio of 0.27x — below the conventional 1.5x liquidity buffer
• Liabilities run 54376.16x equity — a highly leveraged balance sheet worth noting